ML364 structure 
             | 
        Common Name | ML364 | ||
|---|---|---|---|---|
| CAS Number | 1991986-30-1 | Molecular Weight | 517.541 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H18F3N3O3S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
            Use of ML364ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2), and can be used for the research of breast cancer, extracted from patent WO 2016134026 A1, compound Figure 10G.  | 
    
| Name | ML364 | 
|---|---|
| Synonym | More Synonyms | 
| Description | ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2), and can be used for the research of breast cancer, extracted from patent WO 2016134026 A1, compound Figure 10G. | 
|---|---|
| Related Catalog | |
| Target | 
                                    
                                     USP2[1]  | 
                            
| References | 
| Molecular Formula | C24H18F3N3O3S2 | 
|---|---|
| Molecular Weight | 517.541 | 
| Exact Mass | 517.074 | 
| Appearance of Characters | white solid | 
| Storage condition | -20℃ | 
| 2-[(4-methylphenyl)sulfonylamino]-N-(4-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethyl)benzamide |